Jan Walewski
Researcher Next ID · RN-013951
Researcher · Medicine
National Institute of Oncology
, Hungary
- Works count
- 459
- Citation count
- 23,345
- H-index
- 59
- i10-index
- 171
Research interests
Publications
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2015 · 10.1093/annonc/mdv304
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial.
The Lancet Oncology · 2011 · 10.1016/s1470-2045
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
The Lancet Oncology · 2011 · 10.1016/s1470-2045(11)70235-2
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
European Journal of Cancer · 2010 · 10.1016/j.ejca.2010.10.013
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group
The Lancet Oncology · 2006 · 10.1016/s1470-2045(06)70664-7
Current projects
No projects listed.